Evaluation of antioxidant therapy in experimental Chagas disease

Detalhes bibliográficos
Autor(a) principal: Tieghi,Thais de Mello
Data de Publicação: 2017
Outros Autores: Manca,Camilla Chimelo, Garcia,Lígia Cangussu Tomaz, Castanho,Roberto Esteves Pires, Therezo,Altino Luiz Silva, Frei,Fernando, Taipeiro,Elane de Fátima, Martins,Luciamáre Perinetti Alves
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista da Sociedade Brasileira de Medicina Tropical
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822017000200184
Resumo: Abstract INTRODUCTION: Stimulation of inflammatory mediators such as cytokines and chemokines may cause oxidative stress in Chagas disease. In this study, we evaluated the merit of vitamins C and E as antioxidant therapy to minimize the oxidative stress-induced damage in an experimental model of Chagas disease. METHODS: Ninety-six Swiss mice were infected with Trypanosoma cruzi QM2 and treated with vitamins C, E, or both (C/E) for 60 and 120 days, and their effects compared to placebo administration were evaluated in the acute and chronic disease phases. RESULTS: There was no difference in parasitemia among treatment groups. However, histological analysis showed more severe inflammation in the skeletal muscle in the vitamin supplementation groups at both the acute and chronic phases. Biochemical analyses during the acute phase showed increased ferric-reducing ability of plasma (FRAP) and glutathione (GSH) levels in the vitamin C and C/E groups. In the chronic phase, a decrease in GSH levels was observed in the vitamin E group and a decrease in thiobarbituric acid reactive substances (TBARS) was observed in the vitamin C/E group. Moreover, there was a decrease in TBARS in the cardiac tissues of the vitamin C and C/E groups compared to that of the placebo group, although this level was greater in the vitamin E group than in the vitamin C group. CONCLUSIONS: The antioxidant action of vitamins C and E reduced oxidative stress in both the acute and chronic phases of Chagas disease, with a marked effect from joint administration, indicating their inherent synergism.
id SBMT-1_42aee51ae6bfa1318618c7c79505dd11
oai_identifier_str oai:scielo:S0037-86822017000200184
network_acronym_str SBMT-1
network_name_str Revista da Sociedade Brasileira de Medicina Tropical
repository_id_str
spelling Evaluation of antioxidant therapy in experimental Chagas diseaseTrypanosoma cruziTBARSFRAPVitamin CVitamin EAbstract INTRODUCTION: Stimulation of inflammatory mediators such as cytokines and chemokines may cause oxidative stress in Chagas disease. In this study, we evaluated the merit of vitamins C and E as antioxidant therapy to minimize the oxidative stress-induced damage in an experimental model of Chagas disease. METHODS: Ninety-six Swiss mice were infected with Trypanosoma cruzi QM2 and treated with vitamins C, E, or both (C/E) for 60 and 120 days, and their effects compared to placebo administration were evaluated in the acute and chronic disease phases. RESULTS: There was no difference in parasitemia among treatment groups. However, histological analysis showed more severe inflammation in the skeletal muscle in the vitamin supplementation groups at both the acute and chronic phases. Biochemical analyses during the acute phase showed increased ferric-reducing ability of plasma (FRAP) and glutathione (GSH) levels in the vitamin C and C/E groups. In the chronic phase, a decrease in GSH levels was observed in the vitamin E group and a decrease in thiobarbituric acid reactive substances (TBARS) was observed in the vitamin C/E group. Moreover, there was a decrease in TBARS in the cardiac tissues of the vitamin C and C/E groups compared to that of the placebo group, although this level was greater in the vitamin E group than in the vitamin C group. CONCLUSIONS: The antioxidant action of vitamins C and E reduced oxidative stress in both the acute and chronic phases of Chagas disease, with a marked effect from joint administration, indicating their inherent synergism.Sociedade Brasileira de Medicina Tropical - SBMT2017-03-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822017000200184Revista da Sociedade Brasileira de Medicina Tropical v.50 n.2 2017reponame:Revista da Sociedade Brasileira de Medicina Tropicalinstname:Sociedade Brasileira de Medicina Tropical (SBMT)instacron:SBMT10.1590/0037-8682-0451-2016info:eu-repo/semantics/openAccessTieghi,Thais de MelloManca,Camilla ChimeloGarcia,Lígia Cangussu TomazCastanho,Roberto Esteves PiresTherezo,Altino Luiz SilvaFrei,FernandoTaipeiro,Elane de FátimaMartins,Luciamáre Perinetti Alveseng2017-05-12T00:00:00Zoai:scielo:S0037-86822017000200184Revistahttps://www.sbmt.org.br/portal/revista/ONGhttps://old.scielo.br/oai/scielo-oai.php||dalmo@rsbmt.uftm.edu.br|| rsbmt@rsbmt.uftm.edu.br1678-98490037-8682opendoar:2017-05-12T00:00Revista da Sociedade Brasileira de Medicina Tropical - Sociedade Brasileira de Medicina Tropical (SBMT)false
dc.title.none.fl_str_mv Evaluation of antioxidant therapy in experimental Chagas disease
title Evaluation of antioxidant therapy in experimental Chagas disease
spellingShingle Evaluation of antioxidant therapy in experimental Chagas disease
Tieghi,Thais de Mello
Trypanosoma cruzi
TBARS
FRAP
Vitamin C
Vitamin E
title_short Evaluation of antioxidant therapy in experimental Chagas disease
title_full Evaluation of antioxidant therapy in experimental Chagas disease
title_fullStr Evaluation of antioxidant therapy in experimental Chagas disease
title_full_unstemmed Evaluation of antioxidant therapy in experimental Chagas disease
title_sort Evaluation of antioxidant therapy in experimental Chagas disease
author Tieghi,Thais de Mello
author_facet Tieghi,Thais de Mello
Manca,Camilla Chimelo
Garcia,Lígia Cangussu Tomaz
Castanho,Roberto Esteves Pires
Therezo,Altino Luiz Silva
Frei,Fernando
Taipeiro,Elane de Fátima
Martins,Luciamáre Perinetti Alves
author_role author
author2 Manca,Camilla Chimelo
Garcia,Lígia Cangussu Tomaz
Castanho,Roberto Esteves Pires
Therezo,Altino Luiz Silva
Frei,Fernando
Taipeiro,Elane de Fátima
Martins,Luciamáre Perinetti Alves
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Tieghi,Thais de Mello
Manca,Camilla Chimelo
Garcia,Lígia Cangussu Tomaz
Castanho,Roberto Esteves Pires
Therezo,Altino Luiz Silva
Frei,Fernando
Taipeiro,Elane de Fátima
Martins,Luciamáre Perinetti Alves
dc.subject.por.fl_str_mv Trypanosoma cruzi
TBARS
FRAP
Vitamin C
Vitamin E
topic Trypanosoma cruzi
TBARS
FRAP
Vitamin C
Vitamin E
description Abstract INTRODUCTION: Stimulation of inflammatory mediators such as cytokines and chemokines may cause oxidative stress in Chagas disease. In this study, we evaluated the merit of vitamins C and E as antioxidant therapy to minimize the oxidative stress-induced damage in an experimental model of Chagas disease. METHODS: Ninety-six Swiss mice were infected with Trypanosoma cruzi QM2 and treated with vitamins C, E, or both (C/E) for 60 and 120 days, and their effects compared to placebo administration were evaluated in the acute and chronic disease phases. RESULTS: There was no difference in parasitemia among treatment groups. However, histological analysis showed more severe inflammation in the skeletal muscle in the vitamin supplementation groups at both the acute and chronic phases. Biochemical analyses during the acute phase showed increased ferric-reducing ability of plasma (FRAP) and glutathione (GSH) levels in the vitamin C and C/E groups. In the chronic phase, a decrease in GSH levels was observed in the vitamin E group and a decrease in thiobarbituric acid reactive substances (TBARS) was observed in the vitamin C/E group. Moreover, there was a decrease in TBARS in the cardiac tissues of the vitamin C and C/E groups compared to that of the placebo group, although this level was greater in the vitamin E group than in the vitamin C group. CONCLUSIONS: The antioxidant action of vitamins C and E reduced oxidative stress in both the acute and chronic phases of Chagas disease, with a marked effect from joint administration, indicating their inherent synergism.
publishDate 2017
dc.date.none.fl_str_mv 2017-03-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822017000200184
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822017000200184
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/0037-8682-0451-2016
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Medicina Tropical - SBMT
publisher.none.fl_str_mv Sociedade Brasileira de Medicina Tropical - SBMT
dc.source.none.fl_str_mv Revista da Sociedade Brasileira de Medicina Tropical v.50 n.2 2017
reponame:Revista da Sociedade Brasileira de Medicina Tropical
instname:Sociedade Brasileira de Medicina Tropical (SBMT)
instacron:SBMT
instname_str Sociedade Brasileira de Medicina Tropical (SBMT)
instacron_str SBMT
institution SBMT
reponame_str Revista da Sociedade Brasileira de Medicina Tropical
collection Revista da Sociedade Brasileira de Medicina Tropical
repository.name.fl_str_mv Revista da Sociedade Brasileira de Medicina Tropical - Sociedade Brasileira de Medicina Tropical (SBMT)
repository.mail.fl_str_mv ||dalmo@rsbmt.uftm.edu.br|| rsbmt@rsbmt.uftm.edu.br
_version_ 1752122160625745920